
February 27, 2019 Research and Development Business, Senate hearing, USA, pharma, sfc

February 27, 2019 Research and Development Dupixent, Sanofi, pharma, rhinosinusitis

February 27, 2019 Research and Development device, medical technology, neurology, neuroscince, parkinson's cns

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease

February 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, melanoma, patient experience, pharma

February 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

February 22, 2019 Medical Communications, Research and Development MHRA, neo-mercazole, pharma

February 21, 2019 Research and Development Cancer, FDA, Xencor, leukaemia, pharma

February 21, 2019 Research and Development Pfizer, Xeljanz, pharma, rheumatoid arthritis

February 20, 2019 Research and Development Intercept Pharmaceuticals, nash, non-alcoholic steatohepatitis, ocaliva, pharma

February 20, 2019 Research and Development ANDA, Alembic, Gujurat, US FDA, diamox, generics

February 20, 2019 Research and Development

February 20, 2019 Research and Development EU, GMP, Poland, Slovenia, USA, mutual recognition

February 20, 2019 Research and Development Cancer, MSD, keytruda, liver cancer, pharma